FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Meitheal Pharmaceuticals Inc.)

View source ↗

Summary

FDA approves a supplemental application for mycophenolate mofetil from Meitheal Pharmaceuticals, reflecting an updated approval pathway for this generic product…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Transplant Rejection Prophylaxis
• Kidney Transplant Rejection Prophylaxis
• Liver Transplant Rejection Prophylaxis
• Lupus Nephritis

Drugs mentioned

• MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)

Snippet

SUPPL AP for MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)